Skip to main content

AstraZeneca shareholder urges Pfizer rethink

By WTOP Staff

LONDON (AP) — AstraZeneca shareholder Schroders has urged the pharmaceutical firm to reconsider its rejection of a takeover offer from U.S. drugmaker Pfizer.

The fund manager, which holds a 2 percent stake in AstraZeneca, is the biggest shareholder to call publicly for renewed takeover talks.

Schroders said Tuesday it “notes with disappointment the quick rejection by the AstraZeneca board of the latest offer from Pfizer.” It urged AstraZeneca management “to recommence their engagement with Pfizer, and subsequently their shareholders.”

The board of AstraZeneca this week rejected an improved $119 billion takeover offer from Pfizer, saying it significantly undervalued the company and its drug portfolio.

Under British takeover rules Pfizer has until Monday to submit a new offer, but it has said it won’t raise its offer again or launch a hostile takeover bid.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Emergency guide: What you should do to prepare for emergencies

By WTOP Staff
WASHINGTON — Do you know what you'd do if an emergency hits? What if you're at work, your spouse is stuck in traffic and your children are in school? There's no way to plan for every emergency, but you can make sure you're prepared for different scenarios, including making a plan for your family and building a kit of emergency supplies.
Read Next Story

Related News

More than 200 sickened aboard Baltimore cruise ship

Unsafe in any freeze: Some 4WD vehicles have major limitations

Common mistakes for home buyers, and sellers